Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Martinos Center for Biomedical Imaging | OTHER |
Not provided
Not provided
Not provided
The investigators are studying the impact of insulin resistance on the acceleration of brain aging and testing whether increased neuron insulin resistance can be counteracted by utilization of alternate metabolic pathways (e.g., ketones rather than glucose). This study has three Arms, which together provide synergistic data. For all three Arms, subjects are tested in a within-subjects design that consists of 2-3 testing sessions, 1-14 days apart, and counter-balanced for order. Impact of fuel (glucose in one session, ketones in the other) on brain metabolism and associated functioning is measured during each session. For Arms 1-2, the primary experimental measure is functional magnetic resonance imaging (fMRI), which is used to trace the self-organization of functional networks following changes in energy supply and demand. Arm 1 tests the impact of endogenous ketones produced by switching to a low carbohydrate diet, while Arm 2 tests the impact of exogenous ketones consumed as a nutritional supplement. For Arm 3, simultaneous magnetic resonance spectroscopy/positron-emission tomography (MR/PET) is used to quantify the impact of exogenous ketones on production of glutamate and GABA, key neurotransmitters.
Subjects will be given the option to participate in more than one of the Arms, but doing so is not expected nor required.
Prior to scans, subjects will receive a clinician-administered History and Physical (H&P), which includes vital signs, an oral glucose tolerance test (OGTT), and the comprehensive metabolic blood panel. These will be used to assess diabetes, kidney disease, and electrolytes. If subjects pass screening, they will be provided the option to participate in one or more Arms, which include neuroimaging. To provide a quantitative measure of time-varying metabolic activity throughout the scan, based upon quantitative models of glucose and ketone regulation, as well as to be able to implement safety stopping rules (see below), the investigators will obtain pin-prick blood samples three times: prior to the scan, following consumption of the glucose or ketone drink, and following completion of the scan. To assess effects of increased metabolic demand, the investigators measure brain response to cognitive load, transitioning from resting-state to spatial reasoning through a spatial navigation video task. To assess effects of increased metabolic supply, the investigators measure brain response to glucose or ketone bolus.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Arm 1: Metabolic Manipulation via Diet fMRI | Experimental | All subjects are tested three times, each in a different diet-induced metabolic state: glycolytic (glucose burning), fasting (8 hours no food), and ketotic (fat burning). While having their brains scanned with MRI, subjects are initially tested at rest, and then perform a task. Midway through the session, subjects are removed from the scanner and drink up to 75g glucose. Data analyses quantify network reorganization in response to changing energy constraints (i.e., cognitive demand, fuel). |
|
| Arm 2: Metabolic Manipulation via Ketone Supplement fMRI | Experimental | All subjects are tested twice, both times in a fasting condition (8 hours no food, unrestricted water). While having their brains scanned with MRI, subjects are initially tested at rest, and then perform a task. Midway through the session, subjects are removed from the scanner and drink either of two fuel sources. In the ketotic (ketone burning) session they will drink a ketone sports drink dosed at 395mg/kg. During the glycolytic (glucose burning) session the same subjects will drink a bolus of glucose, calorie-matched to the ketones. Data analyses quantify network reorganization in response to changing energy constraints (i.e., cognitive demand, fuel). |
|
| Arm 3: Metabolic Manipulation via Ketone Supplement MR/PET | Experimental | All subjects are tested twice, both times in a fasting condition (8 hours no food, unrestricted water). For both sessions, the investigators will intravenously administer the FDG radioisotope continuously throughout the scan. Thus, PET will map glucose uptake across the brain, while MRS is simultaneously used to measure production of the neurotransmitters glutamine and GABA. While having their brains scanned with MR/PET, subjects are initially tested at rest, and then perform a task. Subjects will drink a ketone sports drink dosed at 395mg/kg. During the glycolytic (glucose burning) session the same subjects will drink a bolus of glucose, calorie-matched to the ketones. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Ketones | Drug | Supplement administered mid-scan. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Diet related changes in brain network stability will be assessed by fMRI BOLD measurements. | Changes in BOLD signal measurements will be observed between baseline and during a glycolytic, fasting, or ketotic state. | Within two weeks of enrollment completion |
| Glucose uptake will be measured by PET, with and without ketone supplement | Continuous FDG PET infusion is used as a measure of glucose uptake during rest and task, with and without the ketone supplement. | Within two weeks of enrollment completion |
| Neurotransmitter production with and without ketone supplement will be measured by magnetic resonance spectroscopy | Changes in neurotransmitter concentration under metabolic demands (i.e., task vs resting-state) with and without ketone supplement will be assessed by magnetic resonance spectroscopy. | Within two weeks of enrollment completion |
| Measure | Description | Time Frame |
|---|---|---|
| Cognitive performance will be assessed by Mini Mental State Exam (MMSE). | All subjects will undergo cognitive testing prior to MRI scanning using the MMSE exam. | Within two weeks of enrollment completion |
| Cognitive performance will be assessed by CNS Vital Signs. |
Not provided
Exclusion Criteria:
Inclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Lilianne Mujica-Parodi, PhD | Contact | 631-371-4413 | lilianne.strey@stonybrook.edu | |
| Liam McMahon, BA | Contact | liam.mcmahon@stonybrook.edu |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Martinos Center for Biomedical Research, Building 149 | Recruiting | Charlestown | Massachusetts | 02129 | United States | |
| Type | Date | Date Unknown |
|---|---|---|
| Release | May 21, 2024 | |
| Reset | Jun 14, 2024 | |
| Release | Apr 7, 2026 | |
| Reset | Apr 28, 2026 |
Not provided
Not provided
| Release Date | Unrelease Date | Unrelease Date Unknown | Reset Date | MCP Release Number |
|---|---|---|---|---|
| May 21, 2024 | Jun 14, 2024 | |||
| Apr 7, 2026 |
| ID | Term |
|---|---|
| D007333 | Insulin Resistance |
| ID | Term |
|---|---|
| D006946 | Hyperinsulinism |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D007659 | Ketones |
| D005947 | Glucose |
| ID | Term |
|---|---|
| D009930 | Organic Chemicals |
| D006601 | Hexoses |
| D009005 | Monosaccharides |
| D000073893 | Sugars |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Glucose | Drug | Supplement administered mid-scan. |
|
All subjects will undergo cognitive testing prior to MRI scanning using the CNS Vital Signs exam. |
| Within two weeks of enrollment completion |
| Insulin resistance will be assessed by HbA1C. | All subjects will be tested for insulin resistance prior to MRI scanning using veinous blood collected and tested for HbA1C. | Within two weeks of enrollment completion |
| Insulin resistance will be assessed by blood insulin level. | All subjects will be tested for insulin resistance prior to MRI scanning using veinous blood collected and tested for insulin during a 2-hour Oral Glucose Tolerance Test (OGTT). | Within two weeks of enrollment completion |
| Insulin resistance will be assessed by blood glucose level. | All subjects will be tested for insulin resistance prior to MRI scanning using veinous blood collected and tested for glucose during a 2-hour Oral Glucose Tolerance Test (OGTT). | Within two weeks of enrollment completion |
| Bioengineering Building , Stony Brook University |
| Recruiting |
| Stony Brook |
| New York |
| 11794 |
| United States |
|
| Apr 28, 2026 |
| D002241 |
| Carbohydrates |